---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/39576335.md"
description: "These leveraged ETFs in biotech are really something I'm too timid to touch; sometimes it feels like playing with fire. Lately, the 2x long positions in CRCL and CRWV have plummeted disastrously (starting at -10%), and even LABU hasn't made much of a splash. Core stocks like XBI are also stagnant. I used to think biotech could offer some big swings, but now I just feel like I'm on a rollercoaster. The faith premium can't be held onto anymore; preserving my capital comes first. I'll be more zen about it. As for bottom-fishing, I'll leave that to time. 🙏"
datetime: "2026-03-27T11:03:22.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39576335.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39576335.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39576335.md)
author: "[usstock_memo](https://longbridge.com/en/profiles/26678806.md)"
---

# These leveraged ETFs in biotech are really somethi…


### Related Stocks

- [CRWV.US](https://longbridge.com/en/quote/CRWV.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [CRCL.US](https://longbridge.com/en/quote/CRCL.US.md)

## Comments (1)

- **看见都头大 · 2026-03-31T14:32:17.000Z**: This is much better than Nasdaq, Nikkei, etc. This month, I swapped S&P Biotech for Nikkei, KOSPI, Nasdaq, and Dow Jones, and suffered huge losses.